Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 0.58% | 177.12 | 0.7% | $1156.59m | |
| LLY | Eli Lilly & Co. | 0.96% | 372.06 | 1.1% | $1068.92m | |
| MRK | Merck & Co., Inc. | 1.06% | 110.08 | 0.7% | $1002.54m | |
| PFE | Pfizer Inc. | 1.09% | 50.25 | 0.9% | $935.84m | |
| ABBV | AbbVie, Inc. | 0.98% | 165.32 | 1.9% | $895.13m | |
| BMY | Bristol-Myers Squibb Co. | 0.01% | 79.93 | 1.1% | $742.00m | |
| AZN | AstraZeneca Plc | 0.42% | 68.85 | 1.0% | $354.37m | |
| HZNP | Horizon Therapeutics Plc | -0.57% | 96.30 | 5.4% | $286.44m | |
| GSK | GSK Plc | -2.74% | 36.88 | 0.3% | $251.05m | |
| IDXX | IDEXX Laboratories, Inc. | 1.13% | 420.10 | 3.9% | $191.38m | |
| NVS | Novartis AG | 1.09% | 91.73 | 0.2% | $188.48m | |
| CTLT | Catalent, Inc. | -2.05% | 47.23 | 1.9% | $170.45m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 5.32% | 231.33 | 8.0% | $168.15m | |
| NVO | Novo Nordisk A/S | -0.42% | 125.26 | 0.1% | $152.07m | |
| SNY | Sanofi | -1.26% | 47.94 | 0.2% | $138.09m |
Company Profile
United Therapeutics Corp. operates as a biotechnology company engaged in the development and commercialization of products for patients with chronic and life-threatening diseases. The firm markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. It is involved in the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. The company was founded by Martine A. Rothblatt on June 26, 1996, and is headquartered in Silver Spring, MD.